Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 13
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Hadjesfandiari N, Khorshidfar M, Devine DV | 2021 | Int J Mol Sci | View Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Blood operators | New or improved product or process |
Diagnostic approach to the adult with unexplained thrombocytopenia | Arnold D, Cuker A | 2021 | UptoDate | View Diagnostic approach to the adult with unexplained thrombocytopenia | Health care providers | Benchmarking and standard setting |
Proposal of the Definition for COVID-19-Associated Coagulopathy | Iba T, Warkentin TE, Thachil J, Levi M, Levy JH | 2021 | J Clin Med | View Proposal of the Definition for COVID-19-Associated Coagulopathy | Health care providers | Clinical research |
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Ting J, Yeung K, Paes B, Chan AKC, Petropoulos JA, Banfield L, Bhatt MD | 2021 | Blood Coagul Fibrinolysis | View How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice | Health care providers | Clinical research |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Saeed S, O’Brien SF, Abe K, Yi Q-L, Rathod B, Wang J, Fazel-Zarandi M, Tuite A, Fisman D, Wood H, Colwill K, Gingras A-C, Drews SJ | 2021 | PLoS One | View Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard | Health care providers | Benchmarking and standard setting |
Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Day D, Lin Y | 2021 | Ontario Regional Blood Coordinating Network September 2021 Newsletter | View Using Blood Wisely One Year Later – Ontario Hospitals Stepping Up to the Challenge | Health care providers | Benchmarking and standard setting |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Marceau D, Huang A, Carr H, Lin Y, Lall R, Graham C, Arsenault C, Sales V, Sidhu D, Semret M, Hamm C, Arhanchiague E, Solh Z, Srour N, Soliman K, Yee C, Laroche V, Nahirniak S, Greenaway C, Pai M, Côté A, Tsang JLY, Cserti-Gazdewich C, Talbot D, Poulin S, Guimaraes R, Rushton-Marovac M, Langlois A, Ning S, Shih A, Boileau M, Singh H, Ledingham D, Ponnampalam A, Yan M, Prokopchuk-Gauk O, Poirier A, Girouard G, Pavenski K, Drouin O, Harris D, Durand M, Rimmer E, Ovakim D, Ménard F, Cuccarolo G, Carruthers J, Lucier K, Arsenault V, Auclair M-C, Avram M, Brassard M, Cerro S, Martinez V, Morin J, Saint-Jacques M, Veillette M, Armali C, Kron A, Modi D, Duncan J, Justumus P, John MS, St-Onge G, Hadzi-Tosev M, Dion P-M, McGillivary L, de Moulliac AV, Nyman SA, Perilli S, Van Vliet PJ, Lane S, Pavenski K, Pereira R, Sirotich E, Abelson J, Greene S, Khandelwal A, Thakar S, Longo S, Anand SP, Benlarbi M, Bourassa C, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Laumaea A, Medjahed H, Prévost J, Richard J, Kaufmann D, Brunet-Ratnasingham E, Chaumont N, Drebot M, Robinson A, Mendoza E, Dimitrova K, Manguiat K, Phillipson C, Chan M, Evans D, Lin J, Boyer L, Cloutier M, Drouin M, Ducas É, Dussault N, Fournier M-J, Landy P, Nolin M-È, Perreault J, Tremblay T, Nazy I, Xie F, Liu D, Wong M, Silverio G, Walkus K, Barton M, Haveman K, Mueller D, Scott A, Moher M, Wood G, Roarty T, Auld F, Carney G, Thomson V, Onell R, Walley K, Donohoe K, Brunk C, Hernandez G, Jacobucci T, Lazosky L, Mann P, Raval G, Zampieri LA, Sekhon M, Wright A, James N, Chang G, Chen R, Deol K, Gantioqui J, Larsen E, Ramdin N, Roche M, Rosinski K, Sham L, Storms M, Gillrie M, Mahe E, Suryanarayan D, Ugarte-Torres A, Robinson T, Gibbs M, Hewsgirard J, Holmes M, McCarthy J, Ody M, Doucette K, Sligl W, Sonpar A, Robertson K, Narayan J, Ravindran L, Stewart B, Zapernick L, Lee S, Sy E, Wong A, Gryzb K, Craddock S, Fuchs D, Myrah D, Sunny S, Harding SR, Kogilwaimath S, Hodgson N, Johnson D, Meier S, Thomson K, Heendeniya A, Houston B, Kenyan Y, Lother S, Olafson K, Rush B, Wuerz T, Solvason D, Albensi L, Alias S, Choi N, Curtis L, Hutmacher M, Kashani H, Lane D, Marten N, Pronyk-Ward T, Rigaux L, Silva R, Tays Q, Naidu R, Mathews J, Mai M, Miceli V, Molson L, Radhakrishnan G, Schaefer L, Haddad M, Landry S, Chernish R, Kruisselbrink R, Liu T, Jeromin J, Siddiqui A, Girolametto C, Krokoszynski K, Main C, Fox-Robichaud A, Rochwerg B, Kruja E, Ellingham D, Sampat D, Tang N, Leto D, Karunakaran M, Ricciuto D, Fusco K, Ghate T, Robinson H, Ball I, Shalhoub S, Slessarev M, Silverman M, Nano E, Bentall T, Campbell E, Kinney J, Parvathy S, Fera E, Delfa AL, Nadarajah J, Solow H, Mendoza E, Engel K, Monaco D, Kononow L, Suntharalingam S, Fralick M, Munshi L, Saeed S, Hajjaj O, Hsu E, Ali K, Duan E, Farjou G, Jenson L, Salib M, Patterson L, Anant S, Ding J, Jomy J, Das P, Geagea A, the Concor-Study Group | 2021 | Nat Med | View Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Health care providers | Clinical research |
Concentré de recherche: Traitement périopératoire des patients atteints de thrombocytopénie immunitaire : comparaison de l’eltrombopag et des immunoglobulines intraveineuses | Arnold DM | 2021 | Blood.ca website | Health care providers | Clinical research | |
High sub-zero organ preservation: A paradigm of nature-inspired strategies | William N, Acker JP | 2021 | Cryobiology | View High sub-zero organ preservation: A paradigm of nature-inspired strategies | Researchers | Basic research |
Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Paredes C, Chi SI, Flint A, Weedmark K, McDonald C, Bearne J, Ramirez-Arcos S, Pagotto F, Baltrus DA | 2021 | Microbiol Resour Announc | View Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Researchers | Benchmarking and standard setting |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Huang CT, Hsu SY, Wang CH, Tseng WJ, Yang CY, Ng CJ, Warkentin TE, Cheng MH | 2021 | Thromb Res | View Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Balitsky AK, Liu Y, Van der Meer PF, Heddle NM, Arnold DM | 2021 | Transfusion | View Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Researchers | Clinical research |
Irradiated, Washed and CMV Seronegative Blood Components | Prokopchuk-Gauk O, Solh Z | 2021 | Clinical Guide to Transfusion | View Irradiated, Washed and CMV Seronegative Blood Components | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Saeed S, Drews SJ, Pambrun C, Yi Q-L, Osmond L, O'Brien SF | 2021 | Transfusion | View SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Researchers | Clinical research |
Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Verma AA, Pai M, Saha S, Bean S, Fralick M, Gibson JL, Greenberg RA, Kwan JL, Lapointe-Shaw L, Tang T, Morris AM, Razak F | 2021 | CMAJ | View Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Health care providers | Benchmarking and standard setting |
Surveillance report 2020 | O'Brien S | 2021 | Blood.ca website | View Surveillance report 2020 | Health care providers | Benchmarking and standard setting |
Répercussions de la COVID-19 sur le don de sang au Canada | Khandelwal A | 2021 | Blood.ca website | View Répercussions de la COVID-19 sur le don de sang au Canada | Health care providers | Benchmarking and standard setting |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Health care providers | Benchmarking and standard setting |
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZAA, Shroff A, Lessard M-C, Blais N, Kelton JG, Nazy I | 2021 | N Engl J Med | View Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Clinical research |
ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Abe T | 2021 | Blood.ca website | View ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Health care providers | Clinical research |
A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Kron AT, Collins A, Cserti-Gazdewich C, Pendergrast J, Webert K, Lieberman L, Zeller MP, Harding SR, Nahirniak S, Prokopchuk-Gauk O, Lin Y, Mendez B, Armali C, Lee C, Watson D, Arnott D, Xun F, Blain H, Panchuk H, Hughes H, Chorneyko K, Angers M, Pilutti N, Lett R, Dowsley S, Ruijs T, Cupido T, Kichinko T, Thompson T, Afshar-Ghotli Z, Callum J, University of Toronto Quality in Utilization, Education and Safety in Transfusion (QUEST) Research Program | 2021 | Transfusion | View A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Health care providers | Clinical research |
Tantalum-containing meso-porous glass fibres for hemostatic applications | Nagrath M, Rahimnejad Yazdi A, Rafferty A, Daly D, Rahman SU, Gallant RC, Ni H, Arany PR, Towler MR | 2021 | Mater Today Commun | View Tantalum-containing meso-porous glass fibres for hemostatic applications | Researchers | Basic research |
Genome Sequence of Staphylococcus aureus Strain CBS2016-05, Isolated from Contaminated Platelet Concentrates in Canada | Yousuf B, Flint A, Weedmark K, Pagotto F, Ramirez-Arcos S, Hotopp JCD | 2021 | Microbiol Resour Announc | View Genome Sequence of Staphylococcus aureus Strain CBS2016-05, Isolated from Contaminated Platelet Concentrates in Canada | Researchers | Benchmarking and standard setting |
Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Ma Y, Hadjesfandiari N, Doschak M, Devine D, Tonelli M, Unsworth L | 2021 | Langmuir | View Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Researchers | Basic research |
A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Jiang D, Lim W, Crowther M, Garcia D | 2021 | Blood Adv | View A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Researchers | Clinical research |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair M-C, Cerro S, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Researchers | Clinical research |
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life | Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB | 2021 | Am J Hematol | View Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life | Researchers | Clinical research |
An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Montemayor C, Simone A, Long J, Montemayor O, Delvadia B, Rivera R, Lewis KL, Shahsavari S, Gandla D, Dura K, Krishnan US, Wendzel NC, Elavia N, Grissom S, Karagianni P, Bueno M, Loy D, Cacanindin R, McLaughlin S, Tynuv M, Brunker PAR, Roback J, Adams S, Smith H, Biesecker L, Klein HG | 2021 | Vox Sang | View An open-source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing | Health care providers | New or improved product or process |
Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Enok Bonong PR, Buteau C, Delage G, Tanner JE, Lacroix J, Duval M, Laporte L, Tucci M, Robitaille N, Spinella PC, Cuvelier G, Vercauteren S, Lewis V, Fearon M, Drews SJ, Alfieri C, Trottier H | 2021 | Transfusion | View Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study) | Health care providers | Clinical research |
Editorial on Thaler et al. long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res 2021 in press | Warkentin TE, Pai M | 2021 | Thromb Res | View Editorial on Thaler et al. long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia. Thromb Res 2021 in press | Researchers | Clinical research |
Complete Genome Sequence of Staphylococcus aureus CI/BAC/25/13/W, Isolated from Contaminated Platelet Concentrates in England | Paredes C, Chi SI, Flint A, Weedmark K, McDonald C, Bearne J, Ramirez-Arcos S, Pagotto F | 2021 | Microbiol Resour Announc | View Complete Genome Sequence of Staphylococcus aureus CI/BAC/25/13/W, Isolated from Contaminated Platelet Concentrates in England | Researchers | Benchmarking and standard setting |
Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’ | Leong D, Hillis C, Aghel N, Pond G, Seow H | 2021 | Heart | View Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’ | Researchers | Clinical research |
Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Gabe C, Sirotich E, Li N, Ivetic N, Nazy I, Smith J, Kelton JG, Arnold DM | 2021 | Br J Haematol | View Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria | Health care providers | Clinical research |
Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Chi SI, Kumaran D, Zeller M, Ramirez-Arcos S | 2021 | Ann Blood | View Transfusion of a platelet pool contaminated with exotoxin-producing Staphylococcus aureus: a case report | Researchers | Clinical research |
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A | Astermark J, Olsson A, Chelle P, Täckström K, Walger M, Magnusson M, Iorio A | 2021 | Haemophilia | View Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A | Researchers | Clinical research |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleucocyté (PD) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Jahan S, Kaushal R, Pasha R, Pineault N | 2021 | Transfus Med Rev | View Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Researchers | New or improved product or process |
SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Srivastava K, Albasri J, Alsuhaibani OM, Aljasem HA, Bueno MU, Antonacci T, Branch DR, Denomme GA, Flegel WA | 2021 | Transfusion | View SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Researchers | Basic research |
Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Sholzberg M, Arnold DM, Laupacis A | 2021 | CMAJ | View Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Health care providers | Clinical research |
Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
Impact of COVID-19 on blood donation in Canada | Khandelwal A | 2021 | Blood.ca website | View Impact of COVID-19 on blood donation in Canada | Health care providers | Benchmarking and standard setting |
Transfusion-related acute lung injury (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Health care providers | Benchmarking and standard setting |
Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety | Blumenstein I, Shanbhag S, Langguth P, Kalra PA, Zoller H, Lim W | 2021 | Expert Opin Drug Saf | View Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety | Researchers | Basic research |
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis | Pendergrast J, Armali C, Callum J, Cserti-Gazdewich C, Jiwajee A, Lieberman L, Lau W, Lin Y, Parmar N, Pavenski K, Riden LS, Shehata N, Willie-Ramharack K, Tomlinson G, Tong TN, Binnington B, Branch DR | 2021 | Transfusion | View A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis | Researchers | Clinical research |
Tantalum-containing mesoporous bioactive glass powder for hemostasis | Nagrath M, Gallant R, Yazdi AR, Mendonca A, Rahman S, Chiu L, Waldman SD, Ni H, Towler MR | 2021 | J Biomater Appl | View Tantalum-containing mesoporous bioactive glass powder for hemostasis | Researchers | Basic research |
Genome Sequence of Staphylococcus aureus Strain PS/BAC/317/16/W, Isolated from Contaminated Platelet Concentrates in England | Yousuf B, Flint A, Weedmark K, McDonald C, Bearne J, Pagotto F, Ramirez-Arcos S, Hotopp JCD | 2021 | Microbiol Resour Announc | View Genome Sequence of Staphylococcus aureus Strain PS/BAC/317/16/W, Isolated from Contaminated Platelet Concentrates in England | Researchers | Benchmarking and standard setting |